Haem- malignancy Flashcards
what is leukaemia
a group of blood cancers with an increase in white blood cells
what is chronic myeloid leukaemia
Proliferation of myeloid cells - granulocytes and their precursors, other lineages (platelets)
what genetic abnormality is characteristic of chronic myeloid leukaemia (CML)
Philadelphia chromosome- t(9:22)
Philadelphia chromosome results in a new gene-
BCR-ABL1
what are the three phases of CML
chronic phase
accelerated phase
blast phase
how long can the CML chronic phase last and how is it often discovered
can last around 5 years
often asymptomatic discovered incidentally through raised WBC count
CML accelerated phase
high proportion of the cells in the bone marrow and blood (10-20%)
patients become more symptomatic, develop anaemia, thrombocytopenia, and become more immunocompromised
CML blast phase
high proportion of blast cells (>30%)
This phase has severe symptoms and pancytopenia
It is often fatal
CF of CML
asymptomatic
splenomegaly
hyper metabolic symptoms
gout
treatment of CML
tyrosine kinase inhibitors e.g. imatinib
MOA of tyrosine kinase inhibitors e.g. imatinib
Prevents the action of theBCR-ABL fusion protein i.e.this is the abnormal protein produced by the Ph mutation
what is acute myeloid leukaemia
malignant disease of primitive myeloid cells (excess of myeloblasts)
acute myeloid leukaemia common age range
> 60 years
what is acute lymphoblastic leukaemia
Malignant disease of primitive lymphoid cells (lymphoblasts)
what is the most common childhood cancer
acute lymphoblastic leukaemia
what syndrome is ALL often associated with?
Down syndrome
CF of ALL
marrow failure- anaemia, infections, bleeding
leukaemic effects
bone pain
abnormal cells ‘blasts’ features
large size
high nuclear:cytoplasmic ratio
prominent nucleolus
blood film specific to AML
Auer rod- Blast cells have rods inside their cytoplasm
diagnostic tool required for definite diagnosis of AML/ALL
immunophenotyping
multi-agent chemotherapy in AML
intensive chemo (3-4 cycles)
prolonged hospitalisation
multi-agent chemotherapy in ALL
can last up to 2-3 years
different phases of treatment at varying intensity
what is a Hickman line
used to provide long-term central venous access
complications of acute leukaemia
anaemia
neutropenia
thrombocytopenia